NBTY sued
This article was originally published in The Tan Sheet
Executive Summary
Vitamin manufacturer, CEO Scott Rudolph and CFO Harvey Kamil named in class action lawsuit brought by attorneys Paskowitz & Associates, Roy Jacobs & Associates and Charles Piven in New York district court. Filed on behalf of NBTY shareholders who purchased or acquired stock between April 22 and June 16, the suit alleges violations of the Securities Exchange Act in issuing "false and misleading" statements regarding sales results reported in April (1"The Tan Sheet" April 26, 2004, p. 21). The complaint alleges that increased sales in the second quarter were due to specialty promotions, not general marketing improvements, leading Rudolph and Kamil to unload shares and announce a sales decline for the current period (2"The Tan Sheet" June 21, 2004, In Brief)...
You may also be interested in...
NBTY Plans Disney Vitamin Chewables Line As Second Quarter Sales Climb
NBTY is building its children's chewables business with the upcoming launch of several Disney products
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.